|
J Biol Chem, Vol. 275, Issue 4, 2647-2653, January 28, 2000
Molecular Cloning and Characterization of Amida, a Novel Protein
Which Interacts with a Neuron-specific Immediate Early Gene Product
Arc, Contains Novel Nuclear Localization Signals, and Causes Cell Death
in Cultured Cells*
Yasuyuki
Irie,
Kanato
Yamagata ,
Yehua
Gan,
Kaoru
Miyamoto,
Eunju
Do,
Che-Hui
Kuo,
Eiichi
Taira, and
Naomasa
Miki§
From the Department of Pharmacology, Osaka University Medical
School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan and the
Department of Molecular Neurobiology, Tokyo Metropolitan
Institute for Neuroscience, 2-6 Musashidai, Fuchu 183-0042, Japan
 |
ABSTRACT |
Amida was isolated by the yeast two-hybrid system
as a novel protein which associated with Arc, a non-transcriptional
immediate early gene specific to the brain. Amida was confirmed to be
associated with Arc in vitro and in vivo. Amida
shows no homology to known proteins. Amida is ubiquitously expressed,
although it is abundant in the brain. A transfection study revealed
that Amida was localized in the nucleus and after 72 h the
transfected cells underwent apoptosis. Furthermore, we found two
nuclear localization signals and a domain needed for interacting with
Arc was encompassed by two nuclear localization signals.
Co-transfection experiment with Amida and Arc suggested that Amida
transported Arc into the nucleus and negatively regulated Amida-induced
cell death. These results indicate that Arc together with Amida may
modulate cell death in the brain.
 |
INTRODUCTION |
Immediate early genes are induced rapidly and transiently in
response to various stimuli including neuronal activities, growth factors, and long term potentiation, and are thought to play roles in
mediating stimulus-induced neuronal plasticity (1-4) as well as
programmed cell death (PCD)1
or apoptosis (5, 6). These genes can be classified into two groups, one
consists of genes that encode transcription factors, such as Egr3/Pilot
(7), and the other "effector" proteins that directly affect
cellular function, such as tPA (8), rheb (9), cox-2 (10), and Arc (11, 12). Immediate early
genes are also induced in pathologic states. Kindling in the
hippocampus is a typical model of temporal lobe epilepsy, which induces
many immediate early genes including Arc (18). In the case of ischemia (6), the mRNAs of immediate early genes are increased in regions of
the brain known to be most susceptible to ischemia.
Recently, surprising advances have been achieved in the study of PCD or
apoptosis (13). In the central nervous system, PCD has been shown to
play an important role in the normal course of development and in
pathologic states such as ischemia, Alzheimer's disease, Huntington's
disease, and epilepsy (14-16). Neuronal plasticity, which can be
thought of as a kind of differentiation, has been suggested to share a
signal transduction pathway with PCD, but the details are yet to be
determined (17).
Arc is thought to be an immediate early gene encoding an
effector protein, which is proposed to mediate cytoskeletal changes underlying stimulus-induced neuronal plasticity (11). In order to
investigate the function of Arc, we searched for proteins with which it
interacts using the yeast two-hybrid system. Such interacting proteins
may constitute a signal transduction pathway including Arc in neuronal
plasticity or PCD. Here, we report the identification of a novel
protein designated Amida (named after Amida, a Buddhist god who is
believed to come over the dying and give them a comfortable death),
which is associated with Arc, localized in the nucleus and induced
apoptosis when overexpressed in cultured cells.
 |
MATERIALS AND METHODS |
Animals--
Adult male rats (Harlan Sprague-Dawley) were
purchased from Nihon-Dohbutsu Co. (Japan) and cared for in accordance
with the guideline of Experimental Animal Care issued from the Prime
Minister's Office of Japan.
Yeast Two-hybrid Screening--
Two-hybrid screening (19) of a
Gal4 activation domain-tagged rat hippocampus subtracted library, using
the cDNA sequence corresponding to
Ser67-Glu396 of Arc as "bait," was
performed as described previously (20). Transformation of yeast strain
PCY2 with bait constructs and, subsequently, with the library DNA
fusion constructs, was performed as described. Transformants were grown
on -Trp -Leu selective plate, before -galactosidase selection.
-Galactosidase expression was tested on nylon membrane (Amersham
Pharmacia Biotech, Uppsala, Sweden).
Screening and DNA Sequencing--
The subtracted library (10)
was screened under high stringency condition (three time washing in
0.1 × SSC, 0.1% SDS at 60 °C for 20 min) with
Amida cDNA labeled by random priming (Amersham Pharmacia
Biotech, Uppsala Sweden) using [ -32P]dCTP. Both
strands of the full-length cDNA of Amida were sequenced.
Northern Analysis--
Twenty micrograms of total RNA from rat
hippocampus was electrophoresed and blotted on a nylon membrane. This
membrane or a Multiple Northern blot membrane (Origene, Rockville, MD)
was hybridized as described (21). The probe used for Northern analysis was a 700-base pair fragment from the 3' end of the Amida
cDNA. The cDNA fragment was labeled by random priming (Amersham
Pharmacia Biotech) using [ -32P]dCTP.
In Vitro Interaction Assay--
Using the TNT Coupled
Reticulocyte Lysate System (Promega, Madison, WI),
pBluescript-Amida was translated with
[35S]methionine. PC12 cells grown on a 9-cm Petri dish
were washed with PBS and lysed by sonication in IP buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
EDTA, 2 mM Na2VO4, 10 mM sodium fluoride, 1 mM phenylmethylsulfonyl
fluoride, 1% Nonidet P-40). After centrifugation at 15,000 × g for 20 min, the supernatant was used as cell lysate. The
in vitro translation reaction mixture was incubated at
4 °C with continuous rotation for 16 h with the lysate of PC12
cells which express Arc protein abundantly. Then the mixture was
incubated with 10 ml of protein A-agarose suspension (Santa Cruz, Santa Cruz, CA) for another 1 h. After eight washes, immunoprecipitated proteins were separated by 10% SDS-PAGE.
In Vivo Interaction Assay--
For the in vivo
interaction assay, COS-7 cells were cultured on 9-cm Petri dishes and
transiently transfected with 16 µg of pCS2+c-myc-tag-Amida and the same amount of
pEGFP-C1-Arc (pEGFP-C1; CLONTECH, Palo Alto, CA)
using LipofectAMINE reagent (Life Technologies, Inc.). After 48 h,
the cells were washed with PBS and lysed by sonication in IP buffer.
After centrifugation at 15,000 × g for 20 min, the
supernatant was used as cell lysate. The cell lysate was incubated with
10 µg of anti-Myc monoclonal antibody (Oncogene Science, Cambridge,
MA) at 4 °C with continuous rotation for 16 h. Then the mixture
was incubated with 20 µl of protein A-agarose suspension for another
1 h. After eight washes, immunoprecipitated proteins were
separated by 10% SDS-PAGE. Immunoblotting was performed using
anti-Arc-specific antiserum (11) at 1000-fold dilution and detected by
the ECL immunodetection system (Amersham Pharmacia Biotech). An
identical procedure was performed for analysis of Amida deletion
mutants except that the transfected plasmids were the pEGFP-C1 derived
vectors which code EGFP-Amida (wild type), EGFP-D1, EGFP-D2, or EGFP-D3
with pCS2+c-myc-tag-Arc and that the antibody used for
immunoblotting was a polyclonal antibody against GFP
(CLONTECH, Palo Alto, CA).
Morphological Analysis--
COS-7 or NG108-15 cells were grown
on poly-D-lysine-coated chamber slides and apoptosis was
assessed by the use of the DNA-staining dye DAPI. TUNEL staining was
also performed using the Apoptosis Detection System (Promega, Madison,
WI) except that staining was carried out with propidium iodide. Then,
anti-Myc monoclonal antibody was added in 2 mg/ml dilution with 10%
bovine serum albumin, 0.2% Triton X-100 in PBS. After 16 h
incubation at 4 °C, cells were washed in PBS 3 times and incubated
with rhodamine-conjugated goat F(ab')2 fragment to mouse
IgG (Cappel, West Chester, PA) in 1:500 dilution with the same buffer
at 4 °C for 16 h. Finally, cells were washed in PBS three
times, mounted with Slow Fade Antifade (Molecular Probe, Eugene, OR)
and observed by fluorescent microscopy.
Quantification of Ability to Induce Apoptosis--
COS-7 cells
cultured on poly-D-lysine-coated 2-well culture slides were
transiently transfected with pSV40NLS-EGFP-EGFP-C1 (encoding tandem
repeated EGFP fused with the nuclear localization signal of SV40 large
T antigen), pCS2+c-myc-tag-Amida,
pCS2+c-myc-tag-Arc, and pCS2+c-myc-tag in various
combinations. The amount of pSV40NLS-EGFP-EGFP-C1 was always 1/4 of total DNA transfected using Superfect reagent (Qiagen, Germany).
After 72 h, cells were fixed in 4% paraformaldehyde in PBS for 20 min, washed three times with PBS for 5 min each, and stained with DAPI.
After washing three times in PBS for 10 min, cells were mounted and
observed by fluorescent microscopy. Pictures of cells were analyzed by
the following methods. First, EGFP-positive cells were identified and
then pyknotic nuclei observed by DAPI staining of those cells were
counted. Each graph represents at least three independent experiments
performed in duplicate in which about 150 cells were individually
examined. The ratio of pyknotic to total cells was calculated and
statistically analyzed using the t test.
 |
RESULTS |
Isolation of Arc-associated Protein using the Yeast Two-hybrid
Screening System--
Yeast two-hybrid screening was employed to
investigate the function of Arc. A complementary DNA encoding
Ser67-Glu396 of Arc, which was used as bait,
was ligated to the GAL 4-binding domain in plasmid vector pPC97 (20)
for screening of a rat hippocampus cDNA library. This region
contains nearly the full-length amino acid sequence of Arc including
the -spectrin homologous domain. Screening of approximately 200,000 colonies resulted in 15 positive clones. One clone (Amida) had an
insert of 700 base pairs with no homology to known genes.
The cDNA insert of the Amida clone was used to screen a rat
hippocampus cDNA libraries to obtain a full-length cDNA
sequence. Screening over 300,000 clones resulted in three independent
positive clones. One of them contained the start consensus sequence
(22) with an upstream stop codon in an identical frame with the
Amida-Gal4 activation domain fusion protein. This 900-base pair
cDNA contains the full-length coding region of Amida as shown in
Fig. 1.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 1.
cDNA and amino acid sequences of
Amida. The numbers to the right refer to the
last amino acid in each line. The predicted amino acid sequence is
displayed under the corresponding nucleotide sequence.
Underlined regions are novel nuclear localization
signals.
|
|
Amida has no homology with known proteins, but showed significant
homology to a clone (AA895828) from mouse expressed sequence tag (EST)
library. The protein of highest amino acid homology found in a FASTA
data base search was Homo sapiens hepatitis antigen
interacting protein A, which has 28.8% identity in a 177-amino acid overlap.
mRNA Expression of Amida--
The expression of Amida mRNA
was investigated by Northern blot. Analysis with 2 mg of poly(A) RNA
revealed that expression of Amida is ubiquitous, but abundant in the
brain (Fig. 2A). Transcripts of approximately 1.2 and 1.0 kilobases were found in Northern blot.
Maximal electroconvulsive seizure with pretreatment with cycloheximide,
which superinduce immediate early genes in the hippocampus, did not
increase the mRNA (Fig. 2B). Amida mRNA was mainly
detected in the hippocampus and dentate gyrus by in situ hybridization (data not shown).

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 2.
mRNA expression of Amida.
A, Northern analysis of 2 µg of poly(A) RNA per lane
prepared from the brain (lane 1), heart (lane 2),
kidney (lane 3), spleen (lane 4), thymus
(lane 5), or liver (lane 6). B,
Northern analysis of 20 µg of total RNA per lane prepared from the
control hippocampus (lane 1) and the hippocampus (lane
2) from the maximal electroconvulsive seizure rat stimulated at 30 min after pretreatment of 20 mg/kg cycloheximide.
|
|
Amida Protein Is Associated to Arc in Vitro--
To confirm that
Amida is associated to Arc, a reconstruction experiment in
vitro was performed. Amida protein was translated in
vitro and [35S]methionine-labeled using the
reticulocyte lysate system. The predicted molecular mass of Amida
protein is about 30 kDa, but the in vitro translated product
migrated as 46 kDa in SDS-PAGE. This discrepancy may be due to the
acidity. The mixture was incubated with the lysate of PC12 cells which
abundantly express Arc protein. Then, immunoprecipitation with
anti-Arc-specific antiserum was performed. Labeled Amida protein was
specifically co-precipitated, while the in vitro translated
products of other clones were not (Fig.
3A).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
Amida is associated with Arc in
vitro and in vivo. A,
in vitro association of Amida and Arc. In vitro
translated and 35S-labeled Amida was incubated with lysate
from PC12 cells which express Arc protein abundantly. Then
immunoprecipitation using anti-Arc antibody and SDS-PAGE were
performed. Lane 1 represents Amida. Lanes 2 and
3 show the other two-hybrid positive clones which could not
bind Arc protein under these conditions. B, in
vivo association of Amida and Arc. COS-7 cells were co-transfected
with pEGFP-C1-Arc and pCS2+c-myc-tag-Amida. After 48 h
transfection, the lysate was immunoblotted with anti-Arc antibody
(lane 1). Lane 2, the lysate was
immumoprecipitated with anti-Myc monoclonal antibody and then EGFP-Arc
was detected with anti-Arc antibody. Lane 3, pCS2+c-myc and pEGFP-C1-Arc were co-transfected as a
control. C, no association of Amida with EGFP. Lane
1, Myc-tag-Amida (Amida-MT) and EGFP were co-expressed
in COS-7 cells and the lysate was immunoblotted with anti-Myc antibody
(lane 1) or with anti-EGFP antibody (lanes 2-4).
The lysate (lane 2) was also immunoprecipitated with
anti-Myc antibody, and the resultant supernatant (lane 3)
and precipitate (lane 4) were immunoblotted with anti-EGFP
antibody.
|
|
Amida Protein Is Associated to Arc in Vivo--
For the in
vivo interaction assay, COS-7 cells were transiently transfected
with both Myc-tagged Amida and EGFP-Arc fusion proteins. After 48 h, cells were lysed and immunoprecipitated with anti-Myc monoclonal
antibody. The immunoprecipitated proteins were analyzed by SDS-PAGE.
Immunoblotting was performed using anti-EGFP-specific antiserum (Fig.
3B). EGFP-Arc fusion protein of 80 kDa was specifically
precipitated with Myc-tagged Amida protein, while no signal was seen
when control Myc-tag peptide was co-expressed.
Furthermore, we tried to examine whether Amida interacts with the
other proteins nonspecifically or not. When Myc-tagged (MT) Amida and
EGFP were co-transfected in COS-7 cells and then the cell lysate was
immunoprecipitated with anti-Myc antibody, Amida did not associate with
EGFP (Fig. 3C).
Amida Protein Is Localized in the Nucleus and Is Involved in
Apoptosis--
To investigate the function of Amida in cells, a
mammalian expression vector pEGFP-C1-Amida which encodes an EGFP-Amida
fusion protein was transiently transfected into COS-7 cells. An intense fluorescent signal was exclusively detected inside the nucleus (Fig.
4, B and C), while
the signal was seen diffusely throughout the cell which expresses only
EGFP (Fig. 4A). Three days after transfection, most of the
COS-7 cells expressing the EGFP-Amida fusion protein showed a small and
round morphology which is characteristic of cells undergoing apoptosis.
Fluorescent microscopic observation by DAPI staining revealed that only
EGFP-Amida positive cells exhibited nuclear condensation and
fragmentation (Fig. 4, D and E). Similar changes
were seen in other cell lines such as NG108-15 (data not shown).

View larger version (90K):
[in this window]
[in a new window]
|
Fig. 4.
Amida protein localizes in the nucleus and
induces apoptosis. A mammalian expression vector encoding EGFP
(A) or EGFP-Amida fusion protein (B) was
transiently transfected into COS-7 cells. DAPI staining of the same
field as B is shown to allow visualization of the nucleus
(C). Arrows indicate the same positions in
B and C. The morphology of COS-7 cells 72 h
after transfection (D) and the same cells stained with DAPI
(E). Condensation and fragmentation of the nuclei of
Amida-transfected cells were seen. NG108-15 cells were also transfected
with the same expression vector containing the Myc-tagged Amida
(F-H). F shows immunocytochemistry using anti-Myc
monoclonal antibody with rhodamine. TUNEL staining using fluorescein
isothiocyanate is shown in G. Superimpose of fluorescein
isothiocyanate and rhodamine staining indicates that the TUNEL positive
cell is expressing Amida (H). Scale bar, 10 µm.
|
|
To confirm that the Amida expressing cells were dying by apoptosis, a
double staining study using the TUNEL reaction and immunocytochemistry against Myc-tag was performed. Most of the NG108-15 cells expressing Myc-tagged Amida were TUNEL positive (Fig. 4, F,
G, and H), while few cells transfected with
vector alone showed a positive TUNEL response.
Amida Contains Two Novel Nuclear Localization Signals--
It was
thought that Amida has two putative nuclear localization signals which
abundantly contain positively charged residues such as lysine or
arginine. Deletion mutants D1, D2, and D3 as shown in Fig.
5 were designed to evaluate these
putative nuclear localization signals (NLS1 and NLS2) and transfected
into COS-7 cells.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 5.
Constructs of Amida deletion mutants.
Deletion mutants D1, D2, and D3 were designed to evaluate the putative
nuclear localization signals NLS1 and NLS2. The abilities of each
mutant for the association with Arc, nuclear localization and cell
death are summarized. +++, high; ++, medium, +, low; ±, slight; , no
activity.
|
|
EGFP-D1 and EGFP-D2 showed nuclear localization (Fig.
6, B and C) as was
the case of EGFP-Amida (wild type, Fig. 6A). But EGFP-D3,
which has neither of the putative NLSs, was distributed throughout the
cytoplasm and a showed similar pattern to EGFP alone (Fig.
6D). As EGFP and EGFP-D3 proteins are both small (26 and 37 kDa, respectively), these proteins could be transported diffusely into
the nucleus. To confirm that D3 does not localize in nucleus, an
expression vector which encodes a large double-EGFP (tandem fused two
EGFPs)-D3 fusion protein of 60 kDa was constructed. Double-EGFP-D3 was
exclusively distributed in the cytoplasm (Fig. 7E) as was double-EGFP alone
(Fig. 7A).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
Morphological analyses to determine the
effects of the nuclear localization signals. Intracellular
distribution of EGFP fusion proteins of each deletion construct was
examined. Note the distribution of wild type (A), D1
(B), and D2 (C) fusion proteins in the nuclei and
EGFP-D3 (D) fusion protein in the cytoplasm. NLS1 or NLS2
was fused to double-EGFP (tandemly fused two EGFPs) and transfected
into COS-7 cells. Note that double-EGFP-NLS1 (E and F) and
double-EGFP-NLS2 (G and H) are localized in the
nuclei. F and H show the DAPI staining of
E and G, respectively. Scale bar, 10 µm.
|
|

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 7.
Analysis of nuclear localization and cell
death induction by D3. Double-EGFP (two tandemly fused EGFPs)
(A) and NLS of SV40 large-T antigen tagged with double-EGFP
(C) were transfected into COS-7 cells. Transfections of a
double-EGFP-D3 fusion protein of 60 kDa (E) and double
EGFP-SV40NLS-D3 (G). B, D, F, and H,
DAPI staining as the same fields of A, C, E, and
G, respectively. Arrows in D show
healthy morphology of the nuclei and in H induced cell
death. Scale bar, 10 µm.
|
|
Furthermore, we investigated whether NLS1 and NLS2 are really novel
nuclear localization signals. cDNA sequences which encode NLS1 or
NLS2 were ligated to double-EGFP and transfected into COS-7 cells.
Double-EGFP-NLS1 (Fig. 6, E and F) and
double-EGFP-NLS2 (Fig. 6, G and H) localized in
the nucleus as did a fusion protein which consists of a NLS from SV40
large T antigen and double-EGFP (Fig. 7, C and
D).
Accumulation of the D3 Region in the Nucleus Causes Cell
Death--
We investigated the ability of each deletion mutant to
promote cell death. COS-7 cells expressing EGFP-D1 or EGFP-D2 fusion proteins showed apoptotic morphology as assessed by DAPI staining 72 h after transfection (data not shown). But, cell death was not
observed, when double-EGFP-D3 was overexpressed (Fig. 7, E and F). A fusion protein consisting of the NLS from SV40
large T antigen and double-EGFP-D3 restored nuclear localization, and exhibited death-promoting ability (Fig. 7, G and
H). These results indicate that the D3 region is sufficient
but nuclear localization of this region is necessary for promotion of
cell death as summarized in Fig. 5.
Analysis of Interaction between Arc and the Deletion
Mutants--
To investigate the domain of Amida which interacts with
Arc, each deletion mutant was co-transfected with Arc and
co-precipitated depicted in Fig. 8.
EGFP-Amida (wild type), EGFP-D1, EGFP-D2, and EGFP-D3 were transiently
expressed in COS-7 cells with Myc-tagged Arc. 48 h after
transfection, the cells were lysed and immunoprecipitation using
anti-Myc monoclonal antibody was performed. The immunoprecipitate was
immunoblotted with anti-GFP antibody (Fig. 8, IP: D1, D2, D3).
EGFP-Amida (wild type), EGFP-D1, and EGFP-D2 fusion proteins could
interact with Myc peptide-tagged Arc protein strongly, while EGFP-D3
interacted with Arc only weakly. A control experiment was carried out
using a vector which encodes only EGFP peptide, which had no ability to
interact with Myc-tagged Arc (Data not shown).

View larger version (93K):
[in this window]
[in a new window]
|
Fig. 8.
Co-precipitation of the proteins from Amida
deletion mutants and Arc. Immunoblotting with anti-EGFP antibody
was carried out in the lysates of COS-7 cells which express the Amida
deletion mutant-EGFP fusion proteins (lysate: WT, D1, D2,
and D3). Each deletion mutant-EGFP fusion protein was
co-expressed with Myc-tagged Arc protein, and the lysates were
immunoprecipitated with anti-Myc peptide antibody and detected with
anti-EGFP antibody (IP: WT, D1, D2, and D3). Note
that only a faint band was visible in D3 mutant expressing cell
lysate.
|
|
Amida Influences Subcellular Localization of Arc--
We
investigated the co-operative function of Arc and Amida. When EGFP-Arc
was expressed alone in COS-7 cells, it showed a punctate and
perinuclear distribution in the cytoplasm (Fig.
9A). In contrast, EGFP-Arc was
distributed in the nucleus when it was co-expressed with Myc-tagged
Amida (Fig. 9C).

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 9.
Amida changes the subcellular distribution of
Arc. COS-7 cells were transfected with pEGFP-C1-Arc and EGFP
fluorescence was detected (A). COS-7 cells co-transfected
with pEGFP-C1-Arc and pCS2+c-myc-tag-Amida (C).
B and D, DAPI staining. Scale bar,
10 µm.
|
|
Arc Inhibited Cell Death Caused by Amida--
To investigate the
function of Arc on Amida-induced cell death, COS-7 cells were
transiently transfected with pSV40NLS-EGFP-EGFP-C1 (encoding tandem
repeated EGFP fused with the nuclear localization signal of SV40 large
T antigen) in various combinations with
pCS2+c-myc-tag(MT)-Amida, pCS2 + c-myc-tag-Arc,
pCS2+c-myc-tag. A constant amount of pSV40NLS-EGFP-EGFP-C1 was used to be always 1/4 of the total DNA transfected. After
72 h, cells were fixed and stained with DAPI. At first, EGFP
positive cells were checked and then the number of those cells that had pyknotic nuclei after staining with DAPI were counted. The proportion of cells with pyknotic nuclei from the EGFP-positive cells were calculated and analyzed with the statistical t test (Fig.
10). Overexpression of Amida
significantly increased the proportion of pyknotic nuclei, while Arc
had no influence on cell death compared with vector alone (Fig. 9,
A and B). Co-transfection of Arc and Amida (99:1,
w/w of transfected plasmids), which represents close to physiological
proportions of Arc and Amida in the dentate gyrus, revealed that Arc
inhibited cell death induced by Amida when compared with the result of
co-transfection of vector and Amida (99:1, w/w) (Fig. 9). These results
indicate that Arc has no influence on cell death alone, but inhibits
cell death induced by overexpression of Amida.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 10.
Suppression by Arc of cell death caused by
Amida. COS-7 cells were transiently transfected with
pSV40NLS-EGFP-EGFP-C1 (encoding tandemly repeated EGFP fused with
nuclear localization signal of SV40 large T antigen) in various
combinations with pCS2+c-myc-tag(MT)-Amida,
pCS2+c-myc-tag-Arc. After 72 h, cells were fixed and
stained with DAPI. EGFP-positive cells were identified and then cells
showing pyknotic nuclei after staining with DAPI were counted. The
proportion of pyknotic nuclei to EGFP positive cells is represented.
pCS2+MT, first column; pCS2+MT-Amida, second
column; pCS2+MT-Arc and pCS2+MT-Amida, third column;
pCS2+MT and pCS2+MT-Amida fourth column. *,
p < 0.01.
|
|
 |
DISCUSSION |
We have isolated a novel protein designated Amida which interacts
with Arc by yeast two-hybrid system, and confirmed that Amida has the
ability to associate with Arc in an in vitro reconstruction assay and in transfected cells. Northern blot analysis revealed that
Amida has two major transcripts of 1.0 and 1.2 kilobases. As
reverse transcriptase-polymerase chain reaction using primers from the
5'- and 3'-regions of the coding region produced a single band, the two
transcripts may differ in the non-coding regions.
Many peripheral tissues also contain Amida mRNA less
than level of that in the brain, although Arc is expressed at low level. In the thymus a band of 4 kilobases was also
detected in Northern blot analysis, but we have not analyzed it yet.
Amida expression was also detected in PC12, C6 glioma, and
NG108-15 cell lines. Compared with the dramatic induction of
Arc after maximal electroconvulsive seizure (11), the
increase of Amida expression in the dentate gyrus induced by
maximal electroconvulsive seizure was not observed even after
cycloheximide administration. These data indicate that Amida is
expressed constitutively in the brain.
To assess the function of Amida, EGFP-Amida fusion protein was
expressed in COS-7 cells and NG108-15 cells. We found that Amida
protein is transported into the nucleus. Three days after transfection,
most of COS-7 cells expressing EGFP-Amida fusion protein began to show
a small and round morphology which is characteristic of apoptosis. We
confirmed that this phenomenon is apoptosis by staining the cells with
DAPI, nucleic acid fluorescent dye. A double staining study with the
TUNEL reaction and immunocytochemistry against Myc-tag also confirmed
that the mode of cell death in Amida expressing cells appears
apoptosis. In a preliminary data, inhibition of caspase 1 did not
attenuate cell death induced by overexpression of Amida.
We demonstrated that both NLS1 and NLS2 are novel NLSs (Fig. 6). These
NLSs are characteristic in that they are rich in arginine residues
instead of lysine residues. Since double EGFP-D3 fusion protein did not
enter the nucleus, it did not cause apoptosis. However, double EGFP-D3
fusion protein conjugated with a foreign NLS (SV40 large T
antigen-derived NLS) induced apoptosis. This phenomenon indicates that
the location of D3 in nucleus is responsible for apoptosis. The similar
finding has been reported that nuclear localization of overexpressed
huntingtin mutant is necessary for apoptosis in primary cultured
striatal neurons (23). Further experiments are necessary to determine
the precise region of Amida responsible for the mechanisms of apoptosis.
Arc-EGFP expressed alone in COS-7 cells showed punctate and perinuclear
distribution (Fig. 9). This pattern of distribution has been reported
for the proteins which associate with cytoplasmic vesicles such as
endocytotic compartments, exocytotic compartments (24, 25), or
mitochondria (26). The cytosolic punctate pattern of Arc-EGFP
distribution was, however, changed to a homogeneous nuclear one when it
was co-expressed with Amida. These data indicate that Amida forms a
complex with Arc and transports it into the nucleus. We also found that
Arc suppressed the apoptosis triggered by overexpression of Amida, when
they were co-transfected (Fig. 10). This result suggests a novel
function of Arc in negatively modulating cell death, although further
investigations using more physiological conditions are required. Taken
together, our data suggest that Arc may interfere with programmed cell
death by interacting with Amida and modulate the apoptotic function of Amida.
 |
ACKNOWLEDGEMENTS |
We thank Dr. P. F. Worley (Dept. of
Neuroscience, Neurology, Psychiatry and Behavioral Science, Johns
Hopkins University, School of Medicine, Baltimore, MD) for the kind
gift of rat hippocampal libraries, the yeast shuttle vectors for the
two-hybrid system, and yeast strain PCY. Dr. D. Turner (Dept. of
Genetics, Fred Hutchinson Cancer Research Center, Seattle, WA) for the
kind gift of pCS2+MT. Y. Yoneda (Dept. of Anatomy and Cell
Biology, Osaka University Medical School 2-2 Yamadaoka, Suita, Osaka,
Japan) for the suggestion of the study in nuclear localization experiment.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB09495.
§
To whom correspondence should be addressed: Dept. of Pharmacology,
Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-3520; Fax: 81-6-6879-3529; E-mail:
nmiki@pharma1.med.osaka-u.ac.jp.
 |
ABBREVIATIONS |
The abbreviations used are:
PCD, programmed cell
death;
PBS, phosphate-buffered saline;
PAGE, polyacrylamide gel
electrophoresis;
DAPI, 4,6-diamidino-2-phenylindole;
EGFP, enhanced
green fluorescent protein;
NLS, nuclear localization signal.
 |
REFERENCES |
| 1.
|
Goelet, P.,
Castellucci, V. F.,
Schacher, S.,
and Kandel, E. R.
(1986)
Nature
322,
419-422[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Morgan, J. I.,
and Curran, T.
(1989)
Trends Neurosci.
12,
459-462[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Sheng, M.,
and Greenberg, M. E.
(1990)
Neuron
4,
477-485[Medline]
[Order article via Infotrieve]
|
| 4.
|
Worley, P. F.,
Cole, A. J.,
Murphy, T. M.,
Christy, B. A.,
Nakabeppu, Y.,
and Baraban, J. M.
(1990)
Cold Spring Harbor Symp. Quant. Biol.
55,
213-223[Abstract/Free Full Text]
|
| 5.
|
Mesner, P. W.,
Epting, C. L.,
Hegarty, J. L.,
and Green, S. H.
(1995)
J. Neurosci.
15,
7357-7366[Abstract]
|
| 6.
|
Akins, P. T.,
Liu, P. K.,
and Hsu, C, Y.
(1996)
Stroke
27,
1682-1687[Abstract/Free Full Text]
|
| 7.
|
Yamagata, K.,
Kaufmann, W. E.,
Lanathan, A.,
Papapavlou, M.,
Barnes, C. A.,
and Worley, P. F.
(1994)
Learn. Mem.
1,
140-152[Abstract/Free Full Text]
|
| 8.
|
Qian, Z.,
Gilbert, M. E.,
Colicos, M. A.,
Kandel, E. R.,
and Kuhl, D.
(1993)
Nature
361,
453-457[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Yamagata, K.,
Sanders, L. K.,
Kaufmann, W. E.,
Barnes, C. A.,
Nathans, D.,
and Worley, P. F.
(1994)
J. Biol. Chem.
269,
16333-16339[Abstract/Free Full Text]
|
| 10.
|
Yamagata, K.,
Andreasson, K. I.,
Kaufmann, W. E.,
Barnes, C. A.,
and Worley, P. F.
(1993)
Neuron
11,
371-386[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Lyford, G. L.,
Yamagata, K.,
Kaufmann, W. E.,
Barnes, C. A.,
Sanders, L. K.,
Copeland, N. G.,
Gilbert, D. J.,
Jenkins, N. A.,
Lanathan, A.,
and Worley, P. F.
(1995)
Neuron
14,
433-445[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Steward, O.,
Wallace, S.,
Lyford, G. L.,
and Worley, P. F.
(1998)
Neuron
21,
741-751[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Hale, A. J.,
Smith, C. A.,
Sutherland, L. C.,
and Stoneman, V. E.
(1996)
Eur. J. Biochem.
236,
1-26[Medline]
[Order article via Infotrieve]
|
| 14.
|
Gould, E.,
and McEwen, B. S.
(1993)
Curr. Opin. Neurobiol.
3,
676-682[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Coyle, J. T.,
and Puttfarcken, P.
(1993)
Science
262,
689-695[Abstract/Free Full Text]
|
| 16.
|
Du, F.,
Eid, T.,
Lothman, E. W.,
Kohler, C.,
and Schwarcz, R.
(1995)
J. Neurosci.
15,
6301-6313[Abstract/Free Full Text]
|
| 17.
|
Faddis, B. T.,
Hasbani, M. J.,
and GoldBerg, M. P.
(1997)
J. Neurosci.
17,
941-950[Abstract/Free Full Text]
|
| 18.
|
Link, W.,
Konietzko, U.,
Kauselmann, G.,
Krug, M.,
Schwanke, B.,
Frey, U.,
and Kuhl, D.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5832-5836[Abstract/Free Full Text]
|
| 19.
|
Chevray, P. M.,
and Nathans, D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5789-5792[Abstract/Free Full Text]
|
| 20.
|
Li, X. J.,
Li, S. H.,
Sharp, A. H.,
Nucifora, F. C., Jr.,
Schilling, G.,
Lanathan, A.,
Worley, P. F.,
Snyder, S. H.,
and Ross, C. A.
(1995)
Nature
378,
398-402[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Linzer, D. I.,
and Nathans, D.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
4271-4275[Abstract/Free Full Text]
|
| 22.
|
Kozak, M.
(1987)
J. Mol. Biol.
12,
3919-3929
|
| 23.
|
Saudou, F.,
Finkbeiner, S.,
Devys, D.,
and Greenberg, M. E.
(1998)
Cell
95,
55-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Yoon, Y.,
Pitts, K. R.,
Dahan, S.,
and McNiven, M. A.
(1998)
J. Cell Biol.
140,
779-793[Abstract/Free Full Text]
|
| 25.
|
Pouli, A. E.,
Kennedy, H. J.,
Schofield, J. G.,
and Rutter, G. A.
(1998)
Biochem. J.
331,
669-675
|
| 26.
|
Wolter, K. G.,
Hsu, Y. T.,
Smith, C. L.,
Nechushtan, A.,
Xi, X. G.,
and Youle, R. J.
(1997)
J. Cell Biol.
139,
1281-1292[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. B. Kordasiewicz, R. M. Thompson, H. B. Clark, and C. M. Gomez
C-termini of P/Q-type Ca2+ channel {alpha}1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity
Hum. Mol. Genet.,
May 15, 2006;
15(10):
1587 - 1599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jin, Y. Cai, T. Yao, A. J. Gottschalk, L. Florens, S. K. Swanson, J. L. Gutierrez, M. K. Coleman, J. L. Workman, A. Mushegian, et al.
A Mammalian Chromatin Remodeling Complex with Similarities to the Yeast INO80 Complex
J. Biol. Chem.,
December 16, 2005;
280(50):
41207 - 41212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sugiura, K. Iwata, M. Matsuoka, H. Hayashi, T. Takemiya, S. Yasuda, M. Ichikawa, T. Yamauchi, P. Mehlen, T. Haga, et al.
Inhibitory Role of Endophilin 3 in Receptor-mediated Endocytosis
J. Biol. Chem.,
May 28, 2004;
279(22):
23343 - 23348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Grumolato, A. G. Elkahloun, H. Ghzili, D. Alexandre, C. Coulouarn, L. Yon, J.-P. Salier, L. E. Eiden, A. Fournier, H. Vaudry, et al.
Microarray and Suppression Subtractive Hybridization Analyses of Gene Expression in Pheochromocytoma Cells Reveal Pleiotropic Effects of Pituitary Adenylate Cyclase-Activating Polypeptide on Cell Proliferation, Survival, and Adhesion
Endocrinology,
June 1, 2003;
144(6):
2368 - 2379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Roth, F. Stenner-Liewen, K. Pawlowski, A. Godzik, and J. C. Reed
Identification and Characterization of DEDD2, a Death Effector Domain-containing Protein
J. Biol. Chem.,
February 22, 2002;
277(9):
7501 - 7508.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|